NEWS
Differences between intermediates, APIs, excipients, and formulations
Produced in the process steps of APIs, it must undergo further molecular changes or refinement to become a material of APIs.
Dec 10,2024
An API, known in English as Active Pharmaceutical Ingredient, or API for short, is any substance or mixture of substances used in the manufacture of pharmaceuticals.
Dec 10,2024
Developments and trends in the field of APIs
API (Active Pharmaceutical Ingredients), directly translated as the active ingredient of the drug, is the basic substance that constitutes the pharmacological action of the drug.
Dec 10,2024
Strategic attention to the pharmaceutical “chip” - APIs
An Active Pharmaceutical Ingredient (API) is any substance or mixture of substances used in the manufacture of a drug that, when used in pharmaceutical manufacturing, becomes an active ingredient of the drug.
Dec 10,2024
What is the definition of an API? What are the specific classifications of APIs?
API (active pharmaceutical ingredient, usually abbreviated as API), which is defined in China as any substance or mixture of substances used in the manufacture of pharmaceuticals, is the active ingredient of all kinds of preparations.
Dec 10,2024
Pharmaceutical intermediates belong to the chemical or pharmaceutical industry
Pharmaceutical intermediates refer to the intermediate substances needed in the chemical synthesis of drugs, which is a necessary step in the process of drug synthesis.
Dec 10,2024
Pharmaceutical intermediates industry development prospect forecast
The pharmaceutical intermediates industry has a very bright future. Due to the rapid development of the global pharmaceutical market, the demand for pharmaceutical intermediates is increasing.
Dec 10,2024
Pharmaceutical intermediates industry development history
The development of the pharmaceutical intermediates industry can be traced back to the early 20th century, when pharmaceutical intermediates were mainly produced by API producers themselves or provided by chemical producers.
Dec 10,2024